Scientific paper - Original scientific paper
Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study
Pharmaceuticals, 14 (2021), 6; 540. https://doi.org/10.3390/ph14060540


Cite this document

Agić, D., Karnaš, M., Šubarić, D., Lončarić, M., Tomić, S., Karačić, Z. ... Lisjak, M. (2021). Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study. Pharmaceuticals, 14. (6). doi: 10.3390/ph14060540

Agić, Dejan, et al. "Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study." Pharmaceuticals, vol. 14, no. 6, 2021. https://doi.org/10.3390/ph14060540

Agić, Dejan, Maja Karnaš, Domagoj Šubarić, M. Lončarić, S. Tomić, Z. Karačić, Drago Bešlo, et al. "Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study." Pharmaceuticals 14, no. 6 (2021). https://doi.org/10.3390/ph14060540

Agić, D., et al. (2021) 'Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study', Pharmaceuticals, 14(6). doi: 10.3390/ph14060540

Agić D, Karnaš M, Šubarić D, Lončarić M, Tomić S, Karačić Z, and sur.. Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study. Pharmaceuticals [Internet]. 2021 June 05 [cited 2024 December 03];14(6). doi: 10.3390/ph14060540

D. Agić, et al., "Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study", Pharmaceuticals, vol. 14, no. 6, June 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:151:703894. [Accessed: 03 December 2024]